Pamela Esposito

Companies

• Kymera TherapeuticsBoard member Sep 9, 2020 to now¹
• Replimune Group, Inc.Chief Business Officer Jul 19, 2018 to Sep 13, 2023²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• RReplimune Group, Inc. REPL263,436 shares³$2.9M at $10.99Sep 12, 2023
• KTKymera Therapeutics KYMR1,000 shares⁴$108.0K at $108.02May 19, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• May 19, 2026Exercised options 1,000 shares at $31.20 of Kymera Therapeutics⁴
• Mar 20, 2026Sold 1,200 shares at $79.94 of Kymera Therapeutics⁵
• Mar 20, 2026Sold 600 shares at $79.24 of Kymera Therapeutics⁵
• Mar 20, 2026Sold 700 shares at $77.71 of Kymera Therapeutics⁵
• Mar 20, 2026Exercised options 2,500 shares at $49.10 of Kymera Therapeutics⁵
• Feb 20, 2026Sold 600 shares at $88.10 of Kymera Therapeutics⁶
• Feb 20, 2026Sold 1,900 shares at $87.06 of Kymera Therapeutics⁶
• Feb 20, 2026Exercised options 2,500 shares at $49.10 of Kymera Therapeutics⁶
• Jan 20, 2026Sold 200 shares at $68.52 of Kymera Therapeutics⁷
• Jan 20, 2026Sold 4,900 shares at $67.99 of Kymera Therapeutics⁷
• Jan 20, 2026Sold 400 shares at $66.68 of Kymera Therapeutics⁷
• Jan 20, 2026Exercised options 2,500 shares at $49.10 of Kymera Therapeutics⁷
• Jan 20, 2026Exercised options 3,000 shares at $31.20 of Kymera Therapeutics⁷
• Dec 17, 2025Sold 1,000 shares at $84.07 of Kymera Therapeutics⁸
• Dec 17, 2025Sold 4,099 shares at $83.45 of Kymera Therapeutics⁸
• Dec 17, 2025Sold 7,959 shares at $82.34 of Kymera Therapeutics⁸
• Dec 17, 2025Sold 14,505 shares at $81.56 of Kymera Therapeutics⁸
• Dec 17, 2025Exercised options 3,000 shares at $31.20 of Kymera Therapeutics⁸
• Dec 17, 2025Exercised options 12,000 shares at $27.67 of Kymera Therapeutics⁸
• Dec 17, 2025Exercised options 12,563 shares at $49.10 of Kymera Therapeutics⁸
• Jun 3, 2025Sold 5,000 shares at $49.04 of Kymera Therapeutics⁹
• Jun 3, 2025Exercised options 5,000 shares at $29.55 of Kymera Therapeutics⁹
• Dec 2, 2024Sold 2,500 shares at $49.00 of Kymera Therapeutics¹⁰
• Dec 2, 2024Exercised options 2,500 shares at $29.55 of Kymera Therapeutics¹⁰
• Sep 17, 2024Sold 7,150 shares at $48.75 of Kymera Therapeutics¹¹